News & Updates
Filter by Specialty:
Urinary CKD273 predicts early renal damage in primary hypertension
A classifier developed based on 273 urinary peptides (CKD273) can predict new-onset proteinuria in patients with primary hypertension and be used to diagnose those with early renal injury, reports a study. This predictor contributes to the early prevention and treatment of hypertensive nephropathy.
Urinary CKD273 predicts early renal damage in primary hypertension
12 Jul 2023
Subsequent pregnancies in women with peripartum cardiomyopathy tied to adverse events
Subsequent pregnancies (SSPs) may lead to adverse outcomes in women with peripartum cardiomyopathy (PPCM), reveals a study, noting that the normalization of left ventricular function is not an assurance for a positive outcome in SSPs.
Subsequent pregnancies in women with peripartum cardiomyopathy tied to adverse events
07 Jul 2023
Objective type 2 MI tied to higher mortality risk
Outcomes are significantly worse in patients diagnosed with type 2 myocardial infarction (MI) with objective evidence of myocardial ischaemia compared with those with myocardial injury and subjective type 2 MI, reports a study.
Objective type 2 MI tied to higher mortality risk
07 Jul 2023
RAS inhibitors proven beneficial in HFrEF with advanced kidney disease
Use of renin-angiotensin system (RAS) inhibitors results in improved clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and advanced kidney disease, a study has shown.
RAS inhibitors proven beneficial in HFrEF with advanced kidney disease
06 Jul 2023
CV health tool effectively promotes discussions during routine follow-up in cancer survivors
A novel electronic health record (EHR) clinical decision support tool, otherwise called the AH-HA* tool, was effective in promoting cardiovascular health (CVH) discussions among cancer survivors during routine follow-up. This was the primary result of a clinic-randomized, hybrid effectiveness-implementation trial presented at ASCO 2023.